SINTX (NASDAQ: SINT) · 20 hours ago
Quality Control Technician I
SINTX is a company listed on NASDAQ, and they are seeking a Quality Control Technician I. The role involves assisting in day-to-day production tasks, performing quality inspections, and maintaining a clean and safe work environment.
BiotechnologyHealth CareMedical Device
Responsibilities
Assist day-to-day production floor tasks
Follow instructions from supervisors and leads
Perform basic material handling duties
Maintain a clean and safe work environment
Inspect materials or products for quality
Support overall workflow to help meet production goals
Qualification
Required
Accurately reads, understands, follows, and updates required process data and reports
Completes tasks and training/qualifications as assigned
Follows good housekeeping and cleanliness protocols within department
Reviews procedures and provides input to make logical updates
Assist day-to-day production floor tasks
Follow instructions from supervisors and leads
Perform basic material handling duties
Maintain a clean and safe work environment
Inspect materials or products for quality
Support overall workflow to help meet production goals
Attention to detail – ensure accuracy in all task
Strong listening skills – able to follow instruction clearly
Fast learner – quickly adapts to new tasks and processes
Dedication to quality – committed to producing high-quality work
0-3 years of experience
Able to sit, walk, stand, etc. for prolonged periods of time
Able to lift up to 25 lbs., on occasion
Able to work in dusty, noisy areas and wear appropriate PPE such as eye protection, ear plugs, latex or nitrile gloves, etc
Able to read, write, speak English
Able to use microscope, calculator, Microsoft Excel
Company
SINTX (NASDAQ: SINT)
SINTX is an OEM ceramics company that develops and commercializes advanced ceramics for medical applications.
Funding
Current Stage
Public CompanyTotal Funding
$207.88MKey Investors
National Institutes of HealthCrede CapitalGroupHercules Capital
2025-09-08Post Ipo Equity· $3.8M
2025-02-26Post Ipo Equity· $5M
2024-04-03Post Ipo Equity· $1.5M
Recent News
2025-12-01
2025-11-14
Company data provided by crunchbase